London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
You will only have one login account. Registering with multiple accounts is not allowed. Any user found to have more than one account on this site will have all, and any future accounts suspended permanently.
Your email and password must only be used by you. If a post is made under your account, it will be considered that it was posted by yourself.
Your account nickname must not be the same, or contain, listed company names or board members' names.
While debating and discussion is fine, we will not tolerate; rudeness, swearing, insulting posts, personal attacks, or posts which are invasive of another's privacy.
You will not;
discuss illegal or criminal activities.
post any confidential or price sensitive information or that is not public knowledge.
post misleading or false statements regarding the share price and performance. Such posts are deemed as market abuse, and may be reported to the appropriate authorities.
post any private communication, or part thereof, from any other person, including from a member of the board of directors of a listed company. Such posts cannot be verified as true and could be deemed to be misleading.
post any personal details (e.g. email address or phone number).
post live price or level 2 updates.
publish content that is not your original work, or infringes the copyright or other rights of any third party.
post non-constructive, meaningless, one word (or short) non-sense posts.
post links to, or otherwise publish any content containing any form of advertising, promotion for goods and services, spam, or other unsolicited communication.
post any affiliate or referral links, or post anything asking for a referral.
post or otherwise publish any content unrelated to the board or the board's topic.
re-post premium share chat posts on regular share chat.
restrict or inhibit any other user from using the boards.
impersonate any person or entity, including any of our employees or representatives.
post or transmit any content that contains software viruses, files or code designed to interrupt, destroy or limit the functionality of this website or any computer software or equipment.
If you are going to post non-English, please also post an English translation of your post.
If you are going to post non-English, please also post an English translation of your post.
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium and Verified Members
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Another part of the conversation , "light aspirin", british research institutions over a period of 10 years of research, 10 strong funds to prove that "light lysin" can help maintain normal plateboard aggregation, help blood flow health, and no side effects, won the European Health Food Ingredients Exhibition (HIE) "Best Heart Health Innovation Program Award."China is one of the countries with a high incidence of cardiovascular disease, and Tang will work with DSM to develop new cardiovascular health products based on "light lysin".? (1) ?Recending? reply my world will be the law today 12:02 optimistic ?Zan?festing? reply spike JEFF author authentication
attention to $Thomson (SZ300146)$ "Light Lycope" is known as a natural aspirin, is a water-soluble tomato concentrate (Fruitflow).Ten years of research and 10 clinical studies by UK research institutions have confirmed that light lysin can "help maintain normal plateplate aggregation, contribute to blood flow health" and have no side effects.It is the first European food safety authority (EFSA) health new feature certification products, and in 2010 won the European Health Food Ingredients Exhibition (HIE) "Best Heart Health Innovation Program Award" and "Most Innovative Ingredients" two gold awards.Rewards ??? Forward ? Like ? Collection 1 Forward 18 comments 24 Like Complaints Reviews...???? forward all reviews at the same time (18) Most recently the earliest praise spike JEFF author status today 15:29 s old Li Happy Investment: Aspirin is anti-plateplate gathering, Feng brother
Although I am pretty sure Team sunweb (Now team DSM) still use fruitflow, we don't know for sure. The question is. Now that DSM are Main sponsor, will they still use NAMEDSPORT or will they supply there own brand products including one with Fruitflow?
Simple maths shows this to be close here. Very interesting interims due end of month could show 1st half sales close to total sales last year...tho the numbers are small, with no debt we could see an end to the need for raises, not withstanding the elephant in the room of the one due v soon. Tranche2 for me at .71 could come soon? Here's hoping :-)
It seems that PXS could reach critical mass soon. I feel that 2021 could see the snowball start to get big and when it starts to roll there will be little to stop it... Exited for the future here :-) Good research gixer...as always
https://www.aspsk.sk/sk/asp-s-r-o "ASP sro manufactures and distributes healthy nutrition products and preparations intended for special nutrition. It is an unmissable company on the market in all points of sale, such as various retail chains, health food stores, pharmacies, internet sales."
If push comes to shove and you can't find another broker to transfer your shares to, you could always convert your nominee held shares to a paper crrtificate. That would buy you time to work out what to do in the longer term.
Most brokers would charge you about £25 to do that, but I suspect it'd be dearer with IG because that's the way their business model operates ?
I haven´t post here before but I have been reading this board for years, first of all thanks for your posts!
I´m holding around 2 million shares at an average of 1,6p, which I have been holding for a lot of years now as I still believe in the company.
I lived in UK for 12 years, but 2 years ago I came back to Spain due to work, since I moved to Spain I have my shares on an IG account on closings only, as I can´t trade because of not living in UK anymore.
I didn´t have any problems with only being able to sell my shares on my IG platform once I decided to do it, but 2 day ago I received the following message on my account:
"After 31 December, we will no longer be able to offer share dealing accounts to EEA clients. If you have a share dealing account with us, it will therefore be set to ‘closings only’ from 1 January and we will reserve the right to sell your holding and close your account from 31 March. This means that you’ll have at least three months to close your positions or transfer them to another provider."
So, I have till the 31st of March to sell all my portfolio or otherwise IG will do it for me, I don´t think that it is really fair that I to sell my shares at a loose (loosing a lot of money) as I lived in the UK when I bought them.
Does anyone know any solutions? Another broker where I can transfer them or something else..
Should hear in the next week or so if funds have been raised , it was on the 11th Dec last year , hopefully not too much money needed , the only reason they might want more money is to service the new CBEC deal , big orders if they come! will have to be fulfilled .
Cheers Gix. Not niche at all then. In fact, it's a monster section of the population. How many trials will they have to conclude before kicking off the commercial roll out? Rhetorical, There isn't an answer we can see.
Alfisa, fairly high by the looks of it. Metabolic Syndrome Among Adults in China: The 2010 China Noncommunicable Disease Surveillance
Objective: The objective of the study was to evaluate the prevalence of metabolic syndrome and its components in 2010.
The prevalence of the metabolic syndrome was 33.9% (31.0% in men and 36.8% in women), which indicates that metabolic syndrome affects approximately 454 million adults in China. More than half of total adult population was suffering from low high-density lipoprotein cholesterol (HDL-C), and nearly half of participants had high blood pressure. Abdominal obesity and low HDL-C were more prevalent in women than in men, whereas high blood pressure, high blood glucose, and high triglycerides were more common in men. Metabolic syndrome was associated with a higher 10-year coronary heart disease risk after adjustment for potential risk factors and each component of metabolic syndrome as continuous variables.